23,594 Shares in Tempus AI, Inc. $TEM Acquired by Wellington Shields Capital Management LLC

Wellington Shields Capital Management LLC bought a new position in Tempus AI, Inc. (NASDAQ:TEM) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 23,594 shares of the company’s stock, valued at approximately $1,393,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Royal Bank of Canada grew its holdings in Tempus AI by 201.2% during the 1st quarter. Royal Bank of Canada now owns 25,988 shares of the company’s stock valued at $1,253,000 after buying an additional 17,359 shares in the last quarter. Rhumbline Advisers purchased a new stake in Tempus AI during the 1st quarter valued at approximately $116,000. Prudential Financial Inc. purchased a new stake in Tempus AI during the 2nd quarter valued at approximately $276,000. Russell Investments Group Ltd. grew its holdings in Tempus AI by 21.3% during the 2nd quarter. Russell Investments Group Ltd. now owns 6,527 shares of the company’s stock valued at $415,000 after buying an additional 1,146 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in Tempus AI by 2,926.6% during the 2nd quarter. Invesco Ltd. now owns 211,621 shares of the company’s stock valued at $13,446,000 after buying an additional 204,629 shares in the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on TEM shares. Jefferies Financial Group started coverage on shares of Tempus AI in a report on Monday, April 13th. They set an “underperform” rating and a $35.00 price objective for the company. Robert W. Baird started coverage on shares of Tempus AI in a report on Tuesday, February 17th. They set an “outperform” rating and a $59.00 price objective for the company. BTIG Research cut their price objective on shares of Tempus AI from $90.00 to $80.00 and set a “buy” rating for the company in a report on Friday, May 8th. Guggenheim cut their price objective on shares of Tempus AI from $95.00 to $60.00 and set a “buy” rating for the company in a report on Monday, March 30th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $75.00 price objective on shares of Tempus AI in a report on Wednesday, March 11th. Nine analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $68.64.

Insider Activity

In other news, CEO Ryan Fukushima sold 13,550 shares of the stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total transaction of $597,148.50. Following the completion of the transaction, the chief executive officer directly owned 603,558 shares in the company, valued at approximately $26,598,801.06. This represents a 2.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Ryan M. Bartolucci sold 4,116 shares of the stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total value of $181,392.12. Following the transaction, the chief accounting officer owned 74,041 shares of the company’s stock, valued at $3,262,986.87. This represents a 5.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 392,057 shares of company stock worth $18,835,714. 24.26% of the stock is owned by corporate insiders.

Tempus AI Price Performance

NASDAQ TEM opened at $46.18 on Tuesday. The company has a debt-to-equity ratio of 2.96, a quick ratio of 3.15 and a current ratio of 3.31. The company has a market capitalization of $8.29 billion, a P/E ratio of -26.85 and a beta of 3.99. Tempus AI, Inc. has a one year low of $41.73 and a one year high of $104.32. The stock has a 50 day moving average price of $48.82 and a 200-day moving average price of $58.82.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Tuesday, May 5th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. The firm had revenue of $348.12 million during the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The company’s quarterly revenue was up 36.1% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.24) EPS. As a group, equities analysts predict that Tempus AI, Inc. will post -1.35 EPS for the current fiscal year.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.